SCI时时刷

search
+
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
This study aims to define the distribution of direct healthcare costs for people with diabetes treated in two healthcare r...
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial
The increasing occurrence of childhood overweight and obesity has been followed by a substantial increase in youth-onset t...
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study
As treatment agents for diabetes, liraglutide is a long-acting glucagon-like peptide 1 receptor agonist, and dipe...
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)
This study aimed to compare weight loss and glycated hemoglobin (HbA1c)-reduction effects of two obesity-centric, weight-l...
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
In patients with type 2 diabetes (T2D), treatment with sodium–glucose cotransporter-2 (SGLT2) inhibitors has been sh...
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
A substantial evidence base supports the use of sodium-glucose cotransporter-2 inhibitors (SGLT2is) in the treatment of ty...
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial
Prediabetes is a state of subclinical glycemic impairment, bridging normal glucose tolerance and diabetes. Globally, over ...
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design
Insulin is the first-line pharmacologic therapy for women with diabetes in pregnancy. However, conducting well-designed ra...
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus
Aberrant brain functional connectivity network is thought to be related to cognitive impairment in patients with type&...
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity
People with type 2 diabetes are at heightened risk for severe outcomes related to COVID-19 infection, including hospitaliz...
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes
Guidelines recommend screening older people (> 60–65 years) with type 2 diabetes (T2D) for cog...
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist. In the S...
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis
Diabetes is associated with a number of complications, particularly if glycaemic targets are not achieved. Glycaemic contr...
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study
Although the use of application (app)s and wearable devices supporting diabetes treatment has spread rapidly in recent yea...
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
The discovery of long-acting incretin receptor agonists represents a major stride forward in tackling the dual epidemic of...
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes
Long-term effectiveness and durability of glucose-lowering medications are important considerations in managing type&n...
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data
Weight loss has been identified as a key strategy for improving glycemic and metabolic outcomes in people with type&nb...
Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review
Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review
The MiniMed™ 780G is a second-generation automated insulin delivery system that implements a modified proportional&#...
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study
Glycemic control is associated with better outcomes among individuals with type 2 diabetes (T2D). This research e...
Correction to: Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion
Correction to: Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion
The Benchmarking Partnership, Alsager, Cheshire, UKDavid HollandSchool of Medicine, Keele University, Keele, ST5 5BG, Staf...
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review
Poor metabolic control and excess body weight are frequently present in people with type 2 diabetes (PwT2D). A systematic ...
The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease
The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease
Foot disease is a devastating complication of diabetes. For almost 3 decades, the mission of the International Working Gro...
Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States
Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States
Medications used to treat type 2 diabetes (T2D) often require dose escalation to optimize effectiveness. Physician and pat...
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims
The impact of telehealth use on healthcare utilization is limited, especially among Medicaid beneficiaries with type 2 dia...
Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
In recent years, the role of pharmacists has undergone significant transformation to become more patient-centered and invo...
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
The aim of the study was to evaluate the efficacy and safety of fixed-dose combination (FDC) of dapagliflozin (10&nbsp...
Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes
Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes
Diabetic kidney disease (DKD) has become the leading cause of chronic kidney disease and end-stage renal failure in most d...
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Rom...
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies
Carbohydrate restriction has gained increasing popularity as an adjunctive nutritional therapy for diabetes management. Ho...
Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States
Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States
Suboptimal multidisciplinary team collaboration is a barrier to effective health care provision for patients with chronic ...
阅读更多
format_indent_increase